1. Home
  2. LICN vs DARE Comparison

LICN vs DARE Comparison

Compare LICN & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lichen China Limited

LICN

Lichen China Limited

HOLD

Current Price

$0.86

Market Cap

17.1M

Sector

N/A

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$0.72

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LICN
DARE
Founded
2004
2015
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1M
16.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
LICN
DARE
Price
$0.86
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
11.7K
★ 187.9K
Earning Date
10-28-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,807,885.00
Revenue This Year
N/A
$163.80
Revenue Next Year
N/A
$226.14
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.71
$0.69
52 Week High
$9.49
$3.78

Technical Indicators

Market Signals
Indicator
LICN
DARE
Relative Strength Index (RSI) 32.11 36.65
Support Level $0.75 $0.70
Resistance Level $1.12 $0.88
Average True Range (ATR) 0.09 0.05
MACD -0.01 -0.00
Stochastic Oscillator 17.57 2.40

Price Performance

Historical Comparison
LICN
DARE

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational, and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and the sales of financial and taxation training software.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: